Keyphrases
Adenovirus
16%
Age-matched
16%
Anti-spike Antibody
33%
Antibody Function
16%
Antibody Level
16%
Antibody Response
100%
B-CLL
100%
BTKi
16%
CD20
16%
Chronic Lymphocytic Leukemia
66%
Clinical Features
16%
COVID-19 Vaccination
33%
Delta Variant
16%
Failure to Respond
16%
Functional Activity
16%
Healthy Controls
16%
Healthy Donors
16%
Immune Protection
16%
Immune Suppression
16%
Increased Vulnerability
16%
Leukemia Patients
33%
Low Serum
16%
Male Gender
16%
Patient Cohort
16%
Patient Risk
16%
Prophylactic Antibiotics
16%
Response Stability
16%
Revaccination
33%
SARS-CoV-2 Delta Variant
100%
SARS-CoV-2 Infection
33%
Seroconversion
16%
Serum IgA
16%
Specific Antibodies
33%
Targeted Immunotherapy
16%
Titre
16%
Vaccinated Patients
100%
Vaccination
16%
Vaccine Platform
33%
Medicine and Dentistry
Adenoviridae
12%
Antibiotics
12%
Antibodies
25%
Antibody Response
100%
B-Cell Chronic Lymphocytic Leukemia
100%
CD20
12%
Clinical Feature
12%
COVID-19 Vaccination
25%
High Risk Population
12%
Immunity
12%
Immunoglobulin A
12%
Immunoglobulin M
12%
Immunosuppressive Treatment
12%
Immunotherapy
12%
Infection
25%
Messenger RNA
12%
Neutralization
100%
Prophylaxis
12%
Seroconversion
12%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Nursing and Health Professions
Antibodies
40%
Chronic Lymphatic Leukemia
100%
Clinical Feature
20%
High Risk Population
20%
Immunoglobulin A
20%
Immunoglobulin M
20%
Immunosuppressive Treatment
20%
Immunotherapy
20%
Infection
40%
Messenger RNA
20%
Patient with Leukemia
20%
Prophylaxis
20%
Severe Acute Respiratory Syndrome
100%
Spike
60%